Enigma Biomedical USA, Inc. (EB USA) today announced that it has selected two (2) four-repeat tau (4R Tau) protein PET imaging biomarkers to advance into Phase 1 (Ph1) studies. Previously, EB USA ...

AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate UpdateLandmark exclusive option and license deal with Takeda for ...

Our Morphomer Tau and Morphomer a-syn small molecule aggregation ... Phase 1 clinical trial of TDP-43-PET tracer ACI-19626 in genetic frontotemporal dementia (FTD) is ongoing with initial clinical ...

Not the Same. In amyloid-negative people (left) few tangles accumulate over a decade. In amyloid-positives (right), tangles grow faster in women (red) than men (blue). [Courtesy of Gillian Coughlan, ...

Tau silencing gene therapy VY1706 robustly reduced tau mRNA ... Many of our programs are derived from our TRACER™ AAV capsid discovery platform, which we have used to generate novel capsids and ...

Strategies for Developing Tau Imaging Tracers The heterogenous ultrastructural conformations of tau aggregates pose a challenge for radiotracer design. There are several groups working on ...

Department of Chemistry, Massachusetts Institute of Technology, 170 Albany Street, Cambridge, Massachusetts 02139, United States ...

MK compared to the other tracers, and these slides are available so you can all look them up online later, it certainly has the least amount of off target binding, it is the most specific, and it does ...